Skip to main content
SpringerLink
Log in

Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity

  • Original Articles
  • Resistance, Alkylating Drugs-DNA Interaction, Glutathione, Glutathione-S-Transferase
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

We examined the relationship between intracellular levels of glutathione (GSH), glutathione-S-transferase (GST) activity, and the kinetics of DNA cross-links induced by the bifunctional alkylating drugs melphalan (MLN), chlorambucil (CLB), and mechlorethamine (HN2) in a rat mammary carcinoma cell line (WT) and in a subline selected in vitro for primary resistance to MLN (MLNr, 16-fold resistance). MLNr cells exhibit a 2-fold increase in intracellular GSH concentration and an approximately 5-fold increase in GST activity as compared with the parent cells. They are cross-resistant to a variety of drugs, including CLB (6-fold) and HN2 (14-fold). Treatment of WT cells with 30 μm MLN or CLB induced a significant accumulation of DNA-DNA cross-links for up to 8 h, which decreased over a 24-h period. In MLNr cells, no significant cross-link formation was induced by either MLN of CLB at any time between 0 and 24 h. Doses of up to 100 μm MLN failed to induce cross-links in MLNr cells. Formation of cross-links was observed immediately after treatment with HN2 in both cell lines and was followed by a subsequent decrease during a 24-h incubation in drug-free medium. At an equimolar concentration (30 μm), the mumbers of HN2-induced cross-links were significantly lower in MLNr cells than in WT cells. However, treatment of MLNr cells with 60 μm HN2 resulted in cross-link levels similar to those obtained using 30 μm HN2 in WT cells. The 35% decrease in MLN accumulation observed in MLNr cells could not entirely explain the absence of crosslinks, since thin-layer chromatographic analysis demonstrated that both cell lines accumulate a significant amount of MLN and metabolize it to the same extent. Significant amounts of MLN were also detected in nuclei isolated from WT and MLNr cells that had been treated with 30 μm [14C]-MLN. Intracellular depletion of GSH by a nontoxic concentration ofl-buthionine-(S, R)-sulfoximine (BSO, 100 μm; about 70% GSH depletion) significantly sentisized MLNr cells to MLN and increased cross-link formation. A nontoxic concentration (50 μm) of ethacrynic acid (EA, an inhibitor of GST showing some specificity for Yc/Yp subunits) also sensitized MLNr cells to MLN and increased cross-link formation. Our data demonstrate that both EA and BSO are effective modulators of nitrogen mustard cytotoxicity in tumor cells resistant to alkylating drugs. The limited number of cross-links formed in MLNr cells after treatment with MLN or even CLB suggests that efficient repair of drug-DNA monoadducts is operative in these cells and that the increases obtained in the presence of BSO and EA may be related to the involvement of both GSH and GST in drug-DNA interactions such as monoadduct repair.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

MLN:

melphalan

CLB:

chlorambucil

HN2:

mechlorethamine

EA:

ethacrynic acid

BSO:

l-buthionine-(S,R)-sulfoximine

GSH:

glutathione

GST:

glutathione-S-transferase

BCNU:

Carmustine

CDDP:

cis-diamminedichloroplatinum(II)

References

  1. Ahokas JT, Davies C, Ravenscroft PJ, Emmerson BT (1984) Inhibition of glutathione S-transferase by diuretic drugs. Biochem Pharmacol 33: 1929–1932

    Google Scholar 

  2. Ahokas JT, Nocholls FA, Ravenscroft PJ, Emmerson BT (1985) Inhibition of purified rat liver glutathione S-transferase isozymes by diuretic drugs. Biochem Pharmacol 34: 2157–2161

    Google Scholar 

  3. Alaoui-Jamali MA, Yin M-B, Mazzoni A, Bankusli I, Rustum Y (1989) Relationship between cytotoxicity, drug accumulation, DNA damage and repair of human ovarian cancer cells treated with doxorubicin: modulation by the tiapamil analog RO11-2933. Cancer Chemother Pharmacol 25: 77–83

    Google Scholar 

  4. Ali-Osman F (1989) Quenching of DNA cross-link precursors of chloroethylnitrosoureas and attenuation of DNA interstrand crosslinking by glutathione. Cancer Res 49: 5258–5261

    Google Scholar 

  5. Beverly AB, Cucchi AC, Lee BJ, Flatow LJ, Rosowsky A, Frei E III (1986) Alkylating patterns in human cell lines. Cancer Res 46: 4379–4383

    Google Scholar 

  6. Chasseaud LF (1979) The role of glutathione and glutathione-S-transferases in the metabolism of chemical carcinogens and other electrophilic agents. Adv. Cancer Res 28: 175–274

    Google Scholar 

  7. Clapper ML, Buller AL, Smith TM, Tew KD (1978) Glutathione-S-transferases in alkylating agent-resistant cells. In Mantle TJ, Hayes JD, Pickett CB, (eds) Glutathione-S-transferase and carcinogenesis. Taylor and Francis, Philadelphia, pp 213–224

    Google Scholar 

  8. Cole SPC (1986) Rapid chemosensitivity testing of human lung tumor cells using the MTT assay. Cancer Chemother Pharmacol 17: 259–263

    Google Scholar 

  9. Das M, Singh SV, Mukhtar H, Awasthi YC (1986) Differential inhibition of rat and human glutathione S-transferase isoenzymes by plant phenols. Biochem Biophys Res Commun 141: 1170–1176

    Google Scholar 

  10. Dufour M, Panasci LC, Germain JSt, Boulet L (1985) Effects of amino acids on the transport and cytotoxicity of melphalan by human tumor cells. Cancer Chemother Pharmacol 15: 125–131

    Google Scholar 

  11. Dulik DM, Fenselau C, Hilton J (1986) Characterization of melphalan-glutathione adducts whose formation is catalyzed by glutathione transferases. Biochem Pharmacol 35: 3405–3409

    Google Scholar 

  12. Edgren M (1987) Nuclear glutathione and oxygen enhancement of radiosensitivity. Int J Radiat Biol 51: 3–6

    Google Scholar 

  13. Edgren M, Revesz L (1987) Compartimentalised depletion of glutathione in cells treated with buthionine sulphoximine. Br J Radiol 60: 723–724

    Google Scholar 

  14. Ellman GL (1959) Tissue sulfhydryl group. Arch Biochem Biophys 82: 70–77

    Google Scholar 

  15. Fram JR, Woda AB, Wilson MJ, Robichaud N (1990) Characterisation of aquired resistance tocis-diamminedichloroplatinum(II) in BE human colon carcinoma cells. Cancer Res 50: 72–77

    Google Scholar 

  16. Friling RS, Bensimon A, Tichauer Y, Daniel V (1990) Xenobiotic-inducible expression of murine glutathione-S-transferase Ya subunit gene is controlled by an electrophile-responsive element. Proc Natl Acad Sci USA 87: 6258–6262

    Google Scholar 

  17. Gi-Ming L, Ozols RF, Young RC, Hamilton TC (1989) Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines. J Natl Cancer Inst 81: 535–539

    Google Scholar 

  18. Gralla JD, Sasse-Dwight S, Poljak GL (1987) Formation of blocking lesions at identical DNA sequences by the nitrosourea and platinum classes of anticancer drugs. Cancer Res 47: 5092–5096

    Google Scholar 

  19. Griffith OW, Meister A (1979) Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocystine sulfoximine). J Biol Chem 254: 7558–7560

    Google Scholar 

  20. Habig WH, Pabst MJ, Jakoby WB (1981) Glutathione-S-transferase. The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130–7139

    Google Scholar 

  21. Hamilton CT, Winker AM, Louie GK, Batist G, Behrens CB, Tsuruo K, Grotzinger RK, Mckoy MW, Young CR, Ozols FR (1985) Augmentation of Adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and-sensitive human ovarian carcinoma cell lines by buthionine sulfoximine-mediated glutathione depletion. Biochem Pharmacol 34: 2583–2586

    Google Scholar 

  22. Jiang BZ, Bank BB, Hsiang Y-H, Shen T, Potmesil M, Silber R (1989) Lack of drug-induced DNA cross-links in chlorambucil-resistant Chinese hamster ovary cells. Cancer Res 49: 5514–5517

    Google Scholar 

  23. Ketterer B, Meyer DJ (1989) Glutathione transferases: a possible role in the detoxication and repair of DNA and lipid hydroperoxides. Mutat Res 214: 33–40

    Google Scholar 

  24. Kohn KW, Ewig RAG, Erickson LC, Zwelling LA (1981) Measurement of strand breaks and cross-links by alkaline elution. In: Freidberg EC, Hanawalt PC (eds) DNA repair: a laboratory manual of research precedures, vol 1, part B. Marcell Dekker, New York, pp 379–401

    Google Scholar 

  25. Lehnert S, Greene D, Batist G (1989) Radiation response of drug-resistant variants of a human breast cancer cell line. Radiat Res 118: 568–580

    Google Scholar 

  26. Li N, Reddanna P, Thyagaraju K, Reddy CC, Tu CD (1986) Expression of glutathione-S-transferases in rat brains. J Biol Chem 261: 7596–7599

    Google Scholar 

  27. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275

    Google Scholar 

  28. Ozols RF, Louie KG, Plowman J, Behrens BC, Fine RL, Dykes D, Hamilton TC (1987) Enhanced alkylating agent cytotoxicity in human ovarian cancer cells in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione. Biochem Pharmacol 36: 147–153

    Google Scholar 

  29. Pallante SL, Lisek CA, Dulik DM, Fenselau C (1986) Glutathione conjuagtes. Immobilized enzyme synthesis and characterization by fast atom bombardment mass spectrometry. Drug Metab Dispos 14: 313–318

    Google Scholar 

  30. Panasci L, Henderson D, Torres-Garcia SJ, Skalski V, Caplan S, Hutchinson M (1988) Transport, metabolism, and DNA interaction of melphalan in lymphocytes from patients with chronic lymphocytic leukemia. Cancer Res 48: 1972–1976

    Google Scholar 

  31. Roos IAG, Thomson AJ, Mansy S (1974) Interactions of platinum compounds with dinucleotides. J Am Chem Soc 96: 6484–6498

    Google Scholar 

  32. Richon MV, Schulte N, Eastman A (1987) Multiple mechanisms of resistance tocis-diaminedichloroplatinum(II) in murine leukemia L1210 cells. Cancer Res 47: 2056–2061

    Google Scholar 

  33. Schecter RL, Woo A, Duong M, Batist G (1991) In vivo and in vitro mechanisms of drug resistance in a rat mammary carcinoma model. Cancer Res 51: 1434–1442

    Google Scholar 

  34. Smith TM, Evans GC, Doane-Setzer P, Castro MV, Tahir KM, Mannervik B (1989) Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells. Cancer Res 49: 2621–2625

    Google Scholar 

  35. Tew KD, Clapper ML (1988) Glutathione-S-transferases in anticancer resistance. In: Woolley PV, Tew KD (eds) Mechanisms of drug resistance in neoplastic cells. Academic Press, New York, pp 141–159

    Google Scholar 

  36. Tew KD, Bomber AM, Hoffman SJ (1988) Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug-resistant and-sensitive cell lines. Cancer Res 48: 3622–3625

    Google Scholar 

  37. Vistica DT, Toal JN, Rabinowitz M (1978) Amino acid-conferred protection against melphalan-characterization of melphalan transport and correlation of uptake with cytotoxicity in cultured L1210 murine leukemia cells. Biochem Pharmacol 27: 2865–2870

    Google Scholar 

  38. Wang AL, Tew KD (1985) Increased glutathione-S-transferase activity in a cell line with acquired resistance to nitrogen mustards. Cancer Treat Rep 69: 677–682

    Google Scholar 

  39. Xue L-Y, Friedman LR, Oleinick NL (1988) Repair of chromatin damage in glutathione-depleted V79 cells: comparison of oxic and hypoxic conditions. Radiat Res 116: 89–99

    Google Scholar 

  40. Zwelling LA, Michaels S, Schwartz H, Dobson PP, Kohn KW (1981) DNA cross-linking as an indicator of sensitivity and resistance of mouse L1210 leukemia tocis-diamminedichloroplatinum(II) andl-phenylalanine mustard. Cancer Res 41: 640–649

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology and Medicine, The Montreal General Hospital and McGill University, Montreal, Canada

    Moulay A. Alaoui-Jamali, Grazia M. Centurioni, Robyn Schecter, Shirley Lehnert & Gerald Batist

  2. Lady Davis Institute for Medical Research, The Jewish General Hospital, 3755, Cote Ste. Catherine Rd, H3T 1E2, Montreal, P.Q., Canada

    Lawrence Panasci

Authors
  1. Moulay A. Alaoui-Jamali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lawrence Panasci
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Grazia M. Centurioni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robyn Schecter
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shirley Lehnert
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gerald Batist
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This work was supported by research grants from the Cancer Research Society and the National Cancer Institute of Canada

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alaoui-Jamali, M.A., Panasci, L., Centurioni, G.M. et al. Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity. Cancer Chemother. Pharmacol. 30, 341–347 (1992). https://doi.org/10.1007/BF00689960

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00689960

Keywords

Search

Navigation